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Abstract 
Zika virus an arthropod borne virus which causes dengue like symptoms is a global concern that has affected 
thousands of people with mild symptoms and causing more severe symptoms in neonates of infected mothers in 
recent years.  It has been associated with Guillain Barre Syndrome and microcephaly. Guillain Barre Syndrome 
is an autoimmune disorder that causes demyelination of peripheral nerves and motor fibers causing symmetric 
muscle weakness which begins from the lower extremities towards the upper part of the body. Microcephaly is a 
condition in which a baby is born with a small head with incomplete brain development causing mental 
retardation. 
Articles were selected from different databases like PUBMED, BioMed Central, Google Scholar, and Scopus 
were reviewed by the participants drawing out points relevant to this topic and combining them to describe the 
Zika virus infection, modes of transmission and complications associated with it. 
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1. Introduction 
Zika virus (ZIKV) has drawn a global concern because of its emergence as a widespread pandemic, affecting 
thousands of people especially offspring of infected pregnant mothers in the Western hemisphere within the last 
decade [1]. To better deal with ZIKV pandemic, it is important to trace its sequence of events from its origin to 
the current state of affair. ZIKV was first isolated from Rhesus monkey in 1947 in the Zika forest of Uganda 
where it caused minor outbreaks with relatively few cases reported [2,3]. The first cases of ZIKV infection were 
reported in Nigeria, Uganda and Senegal in the 1960s [4].  Zika virus lineage was later identified in the Malaysia 
in 1966, and despite its continuous spread to more geographical areas, diseases reported from the viral infection 
was very rare [3].  
Zika is an arthropod-borne virus because part of its reproductive cycle occurs inside the body of a host 
organism. They are classified under the Flaviviridae family and Flavivirus genus. Other viruses such as dengue, 
Japanese encephalitis, West Nile and yellow fever, are also Flaviviruses [1,2,5,6]. As of 2014, 58 species of 
mosquitoes are found to be present in the Zika Forest in Uganda, where Zika was first isolated. Majority of these 
species belong to the genus Aedes [7]. 
Transmission of ZIKV is primarily by the Aedes aegypti as well as Aedes albopictus (Asian tiger mosquito) 
mosquito vectors, which reside in tropical and European Mediterranean regions respectively [3, 6, 8, 11].  A. 
aegypti are day time biters that thrive in water holding containers [3]. Other arboviruses as stated earlier (dengue 
virus, West Nile, chikungunya virus, and yellow fever virus), are also transmitted by the vectors, Aedes Sp 
mosquitoes [12]. Besides A. aegypti mosquitoes, ZIKV has been reported to be transmitted perinatally [13] 
potentially through sexual intercourse [12, 14] and potentially through blood transfusion [15].  Infection leads to 
a lifelong immunity [13]. 
ZIKV infection is often referred to as a “dengue-like syndrome” because it has similar symptomatic 
manifestations as the dengue virus infection [4].  This can potentially result in the misdiagnosis of patients as 
either ZIKV infected or dengue-virus infected, especially in regions where these two types of viruses are 
prevalent. Symptoms of ZIKV infection ensue about 9 days after mosquito bite [15]. The most common 
symptoms include mild fever lasting one to two days, periarticular swelling, non-purulent conjunctivitis, 
arthralgia, and maculopapular rash [6, 16]. These symptoms serve as one of the basis for the diagnosis of ZIKV. 
However, the Standard diagnostic method for ZIKV is by reverse-transcriptase polymerase chain reaction (RT-
PCR) that tests for viral RNA in serum [2]. 
In 2007, Micronesian Island of Yap experienced the first ZIKV epidemic [3].  It then spreads across the Pacific 
to the West, including South and Central America and the Caribbean. But the largest ZIKV outbreak was 
recorded in French Polynesia between October, 2013, and April, 2014, where 32,000 people were suspected for 
ZIKV infection [2, 12]. As of July, 2016, 65 countries and territories have reported cases of ZIKV transmission 
since 2007. 15 countries and territories worldwide have reported cases of Guillain-Barre syndrome caused by 
ZIKV [17]. 
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Previous studies have reported the potential for ZIKV to cause Guillain-Barre syndrome [18].  However, a 
recent case-study is the first to provide sufficient evidence for and confirm Guillain-Barre syndrome caused by 
ZIKV infection [2]. The study reports the complications of Guillain-Barre syndrome from ZIKV infection, 
following a 20-fold increase in the incidence rate of Guillain-Barre syndrome among ZIKV patients in 
Micronesia and French Polynesia. Data gotten from this study will be used as a basis for our review study in 
confirming the complications of Guillain-Barre syndrome from ZIKV infection [2]. 
Guillain-Barre syndrome is an autoimmune disease that results in the destruction of Schwann cells, causing 
inflammation and demyelination of peripheral nerves and motor fibers. In Guillain-Barre syndrome, antibodies 
against neuronal myelin sheath are formed [6].  Symptoms of Guillain-Barre syndrome include symmetric 
muscle weakness or paralysis beginning in lower extremities and ascending to the upper body, often resulting in 
facial paralysis [19, 20]. Guillain-Barre syndrome is known to be the leading cause of non-traumatic paralysis, 
with men more likely to be affected than women [21]. 
Microcephaly is a rare condition in which a baby is born with small head or in which a baby’s head stops 
growing after birth. In microcephaly, the occipito-frontal circumference measurement of the head is greater than 
two standard deviations below the mean for age and gender [17, 22]. Microcephaly is classified into primary and 
secondary [6]. Primary microcephaly occurs during embryonic development and results in defect in 
neurogenesis or early degenerative processes, while secondary microcephaly occurs postnatally and resulting in 
abnormality in the development and function of the central nervous system [23]. Common symptoms of 
microcephaly include intellectual disability, developmental impairment, seizures, and hearing and vision 
impairment [6].  
The aim of this study is to conduct a literature review about ZIKV infection and its neurological complications 
including Guillain-Barre syndrome and microcephaly, using recent research studies as template. 
2. Materials and methods 
40 articles published between 2007 and 2016 were carefully examined based on the relevance of their contents 
to the topic in study. Of these articles, 10 were selected to carry out this review study. Some of the references of 
these articles were also used in our work, based on their relevance to our topic. These articles were case-control 
studies, review studies, retrospective studies, survey studies and cohort studies. Articles and data collection was 
done using research journals and databases such as Google Scholar, BioMed Central, PubMed and Scopus. 
Some of the journals used were Journal of Virology, Journal of Autoimmunity, Lancet, Emerging Infectious 
diseases, Neuroepidemiology, etc. Key phrases used during the search were ‘Complications associated with Zika 
virus’, ‘Guillain-Barre syndrome and Zika virus’, ‘Microcephaly and Zika‘, ‘Mode of transmission of Zika’ and 
‘Zika virus control and preventive measures’. There were 7 articles between 2012 and 2016, with data showing 
the prevalence and incidence rate of Microcephaly and Guillain-Barre syndrome linked with ZIKV. Of these 
articles, one was selected for our Guillain-Barre analysis based on the large number of cases reported (42 
patients) [2]. Data from the other 6 articles were used for our microcephaly analysis. 18 articles were used to 
obtain information about the history of Zika, complications associated with ZIKV, potential vaccine and 
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treatment methods. According to the articles, the subjects used for data collection were patients who had ZIKV 
or are suffering from ZIKV infection within the past 5 years. Patient’s age, sex, islands of residence, and clinical 
signs and symptoms were taken into account when collecting the data. The subjects were suffering from either 
Guillain-Barre syndrome or microcephaly, or developing the symptoms.  
3. Results and Discussion  
Of all the complications related to ZIKV, microcephaly has been found to be the most common and most 
dangerous. In Central America alone, 25 countries and regions have had cases of ZIKV as of February 2016, 
with reports of a significant increase in microcephaly among neonates caused by ZIKV in Brazil [24]. Following 
ZIKV outbreak in the northeastern region of Brazil in 2015, the Ministry of Health in Brazil (MOH) released a 
bulletin that confirms the relationship between ZIKV infection and microcephaly [6]. There was a significant 
increase in the number of newborns suffering from microcephaly through fetal transmission of the ZIKV from 
affected mothers. Another study also reports a significant rise in the suspected cases of microcephaly associated 
with Zika patients in Brazil from 739 people in November 2015 to 4783 people in January 2016 [6]. 
Microcephaly is a medical condition present at birth, resulting in a small head and decreased brain development 
leading to poor motor function and decreased intellectual ability. Microcephaly can be caused by factors like 
alcohol, tobacco and radiation during pregnancy [25]. In the last few years, Zika virus epidemic has led to an 
increased number of cases of microcephaly in countries like Brazil, French Polynesia, Central America, 
Southeast Asia, Yap Island and Columbia. Zika virus as said earlier is from the family Flaviviridae, transmitted 
by the vector Aedes aegypti and Aedes albopictus [25]. Zika virus can directly cause damage or abnormality to 
fetal brain through the placenta, due to its neurotropic characteristics [25]. A testable hypothesis states that Zika 
virus affects neuroepithelial cells of the fetus at an early stage of development which might not be so because 
the direct exchange of maternal blood to the placenta begins at the 10th week of gestation [25]. Other modes of 
transmission of Zika virus can be by leakage of the virus through trophoblast cells by exocytosis, uterine 
secretion, and diffusion into the amniotic fluid [25]. The transfer of Zika virus during fertilization by infected 
semen allows access to the early embryonic development of the fetus [25]. 
 Another hypothesis was suggests that Zika virus is transmitted at about 12 week of gestation where direct 
exchange of maternal and fetal blood begins [25]. This occurs during the last stage of embryonic development 
[25]. This is also when infected pregnant women show signs of zika virus infection proving the evidence of 
direct viral transmission [25]. 
When testing for Zika virus, the highest amount is mostly found in the fetal membrane, placenta and umbilical 
cord [24]. It is suggested that the virus can cross the placental barrier as a result causing microcephaly or the 
placenta mounts an immune response against the exposure, which contributes to causing the brain defect [25]. 
The role of zika virus in the pathogenesis of microcephaly in fetuses could be attributed to nutrient deficiency 
[26]. GLUT1, the main glucose transporter across the blood brain barrier and placental barrier. A genetic 
GLUT1 deficiency is associated with microcephaly. Researchers are yet to confirm the effect of ZIKV on 
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GLUT1 however inhibition of protein kinase C, an enzyme involved with GLUT1 functionality, has been 
reported to be involved in the replication of dengue virus which is in the same genome as zika virus [27]. 
It is assumed that the viral effect of zika on GLUT1 could inhibit access of the placenta to the glucose needed 
for rapid endothelial growth of fetus thereby causing microcephaly [26]. 
During the week of symptomatic infection, RNA detection in serum or blood is considered to be the diagnostic 
method of choice [28]. ZIKV RNA can be detected in urine for some days longer [29, 30]. ZIKV is also present 
in semen for an unknown length of time, and reports of sexual transmission of ZIKV have emerged [12, 14, 31]. 
Table 1: Maternal symptoms, fetal abnormality, and final diagnosis. 
Week of 
zika 
associated 
symptoms 
+ source 
Mothers’              
symptoms 
Week of 
first 
abnormal 
fetal 
ultrasound 
Fetal head 
circumference 
Fetal 
weight 
Associated fetal 
defect 
Diagnosis 
18 week 
[32] 
Cutaneous rash 
with itching 
21 weeks 30cm - Dilation of 
ventricle, 
hypoplastic 
cerebellum, 
absence of 
cerebral vermis 
Microcephaly 
- [33] - 18 weeks 21.5cm 930g Intracranial 
calcification, 
reduced cortical 
parenchyma, 
lesion of 
posterior fossa, 
hydrothorax, 
subcutaneous 
edema 
Microcephaly, 
hydranencephaly 
and still birth 
11 week 
[34] 
- 20 weeks 24cm - Severe brain 
abnormality, 
reduced head 
circumference 
Microcephaly 
American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) (2016) Volume 24, No  1, pp 151-161 
156 
 
13 week 
[35] 
Musculoskeletal 
and retroocular 
pain, itching, 
maculopapular 
rash 
29 weeks 26cm 1470g Calcification in 
cortex, Wallerian 
degeneration 
Microcephaly 
- [35] - 38 weeks 33cm 3500g Lower limb 
spasm at birth, 
calcification in 
basal ganglia, 
ventriculomegaly, 
chorioretinal scar 
No 
microcephaly 
but presents with 
ophthalmic 
disorder 
26 week 
[36] 
Maculopapular 
rash 
35 weeks 29cm 2000g Abnormal 
umbilical artery 
flow, intrauterine 
growth restriction 
Microcephaly 
8 week 
[35] 
Maculopapular 
rash 
35 weeks 24cm 2300g Cerebral 
calcification, 
abnormal middle 
cerebral artery, 
intrauterine 
growth 
restriction. 
Microcephaly 
22 week 
[36] 
Maculopapular 
rash 
27 weeks 25cm 1400g Placenta 
insufficiency, 
oligohydramnios, 
intrauterine 
growth 
restriction. 
Microcephaly 
25 week 
[36] 
Maculopapular 
rash 
30 weeks 26cm 1500g Fetal death 
detected at 36 
week after 
repeated 
ultrasound 
Stillbirth 
Unknown 
[37] 
Maculopapular 
rash 
30.1 weeks 24.6cm 1179g Brain atrophy, 
coarse 
calcification 
involving white 
matter of the 
frontal lobe 
Microcephaly 
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including 
cerebellum, 
enlarged cisterna 
magna 
 
The articles used in the table above [32 -37] are collected from different countries to prevent selection bias. The 
data includes the maternal symptom associated with Zika virus infection, the week of symptoms, the first 
gestational week of detecting fetal abnormality, the circumference of the fetus head, weight of the fetus, related 
defect of fetus and the final diagnosis. 
From our data in the table, pregnant women present with a maculopapular rash and fever which is a common 
symptom of ZIKV infection. Since most ZIKV infection are asymptomatic [35], most of the pregnant women 
did not show any symptoms which led to late detection of fetal abnormality. The fetuses presented in the table 
were tested positive to having being infected by ZIKV. The weight of the fetus was not present in some result 
because the fetus were terminated before birth and all maternal family history revealed no genetic disease 
relating to microcephaly, still birth, and visual defect. Cerebral Cortex calcification was the most common effect 
of ZIKV related microcephaly with normal cerebellum, brain stem and spinal cord and the PCR assay test was 
negative for all other Flaviviruses and non flavivirus (e.g. HIV, HPV etc.) in each fetus. All fetus presented in 
the table suffered severe brain damage an eye defect associated with ZIKV infection because they all tested 
positive to ZIKV infection [37]. Tests showed that all other organ present in the fetus was normal meaning the 
eye and brain is the main target for defects associated with ZIKV infection [37]. The most common abnormality 
seen is the calcification of the fetal cerebral cortex which is mostly identified at the late stage of gestation [37]. 
Apart from microcephaly and eye defect, ZIKV infection has also been known to cause the premature death of 
the fetus and hydrops fetalis [33]. The absence of symptoms in infected pregnant women may lead to 
hydrocephalus in the fetus and the strain of ZIKV that lead to fetal demise and hydrocephalus was the same as 
the ZIKV outbreak in America and the Caribbean [33]. Ocular defect can be seen in fetus that have been 
infected by ZIKV but does not present with microcephaly [35]. ZIKV can be transferred to the fetus by the 
placenta through blood exchange [35]. It goes to the central nervous system and affects neural cells [32]. 
 The least common complication of ZIKV would be Guillain-Barre syndrome which is an attack on the nervous 
system leading to symptoms like symmetric muscle weakness or paralysis starting from the lower extremities to 
upper body often resulting in facial paralysis [20] as well as varying degree of sensory disturbances and 
movement of cranial nerves [19]. Paralysis caused by Guillain-Barre syndrome affects 1-4 persons per 100,000 
populations every year, making it the leading cause of non-traumatic paralysis [2]. Besides ZIKV, other 
infections can lead to Guillain-Barre syndrome including Epstein-Barr virus infection, upper respiratory 
infections, cytomegalovirus infections and digestive tract infections [2]. Guillain-Barre syndrome has been 
reported to also be caused by other arboviral diseases including chikungunya, West Nile, dengue and Japanese 
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encephalitis [2]. ZIKV and dengue virus have similar symptomatic manifestations, and both has been shown to 
cause Guillain-Barre syndrome [4]. So patients suffering dengue virus can often be misdiagnosed as having 
ZIKV if the standard diagnostic method is not used. According to the reference study used in this article, dengue 
virus was also prevalent at the time of ZIKV outbreak in French Polynesia. To ensure that Guillain-Barre 
syndrome is caused by ZIKV and not just dengue virus, a series of control subjects were used to confirm that 
ZIKV, with or without concurrent of dengue virus can cause Guillain-Barre syndrome.  
 
 
Figure 1: Graph showing the weekly cases of suspected ZIKV infection in French Polynesia between October 
2013 and April 2014, obtained from Cao-Lormeau et al (2016). 
*The numbers of suspected ZIKV infection cases are approximated values. 
In our Guillain-Barre syndrome analysis, we only used one study for analysis [2] because it is the only study 
with a large sample size (n=42) out of all related studies we looked at, where the sample sizes were less than 5. 
This allows for a significant analysis. Figure 1 shows the incidence rate of ZIKV infection and Guillain-Barre 
syndrome, recorded on a weekly basis from October, 2013 (41st week) to April, 2014 (16th week). From figure 1, 
we see the first case of ZIKV infection during the outbreak recorded in the 41st week of 2013, with over 500 
suspected cases reported. The peak of the ZIKV epidemic was recorded on the 49th week with over 3500 
suspected ZIKV cases and 5 cases of Guillain-Barre syndrome. The peak for cases of Guillain-Barre syndrome 
is seen at the 52nd week, which also had over 1500 suspected cases of ZIKV. In total, 42 cases of Guillain-Barre 
syndrome caused by ZIKV were recorded with or without the concurrent of dengue virus, which was also 
epidemic during the outbreak. Based on a calculated attack rate of 66%, the risk of developing Guillain-Barre 
syndrome following ZIKV infection in French Polynesia was estimated to be 0.48 per 2000 ZIKV infection. 
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Till date, there is no known treatment or vaccine for ZIKV [1]. Only some of the symptoms can be treated to 
provide comfort to patients, as well as by taking prevention measures. Implementation of control measures by 
individuals and government in regions or territories where ZIKV is an epidemic is needed to prevent and control 
the spread of ZIKV infection. For individuals, use of mosquito repellants, mosquito nets and air conditioning 
could help reduce risk for mosquito bites. For the government, implementation of policies that will limit or 
control the movement of pregnant mothers to regions/territories where ZIKV is an epidemic could be required. 
Programs to create public awareness of ZIKV epidemic and to educate citizens on possible precautionary 
measures and general mosquito management could also be implemented. 
4. Conclusion 
Zika virus is a mild viral infection that can result in serious complications including Guillain-Barre syndrome 
and microcephaly in neonates of infected mothers. Avoid travelling to endemic areas especially when you are 
trying to conceive. Although reportedly 80% of ZIKV are asymptomatic, severe neurological complications like 
microcephaly and Guillain-Barre syndrome makes it one of the most dangerous viral infection globally. Until 
effective treatments or vaccine for ZIKV is introduced, the best way to combat ZIKV outbreak is by taking 
preventive measures for protection against infected mosquitos especially in endemic areas and by treatments to 
alleviate some of the symptoms. 
Further researches need to be done to further strengthen Guillain-Barre and microcephaly association with 
ZIKV and discover other new possible complications that can result from ZIKV infection. 
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